MSB 7.69% $1.19 mesoblast limited

Ryoncil: ODAC/FDA Meeting Discussion, page-1691

  1. 43 Posts.
    lightbulb Created with Sketch. 118
    Shame we didn't got to hear from each panel member their reasons for voting yes/no. We got as far as the first two yeses: one who didn't like the question because it was too narrow, and one who was unsure, but felt it was a 51%-yes, 49%-no situation.

    My system now says [Event Concluded], so the reasons for the rest, and most importantly the "noes" won't go down in the public record (for now at least). I am interested in the noes because it helps us gauge the chances that FDA will go on to reject in September (a low, but non-zero chance).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.